3170 results for «249»

Filter By

3170 results

Getting ready for tricuspid TEER: key steps in building a successful programme

14 Feb 2026 – From PCR Tokyo Valves 2026

Prepare to establish a successful tricuspid TEER programme by understanding essential components such as systematic echocardiographic and clinical assessments for patient selection, procedural fundamentals, and programme development supported by clinical evidence.

Getting ready for tricuspid TEER: key steps in building a successful programme

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

15 Feb 2026 – From PCR Tokyo Valves 2026

This session delves into the comprehensive management of ischemic heart disease in patients undergoing transcatheter aortic valve implantation (TAVI). It highlights the critical importance of maintaining coronary access post-TAVI and explores how various valve designs affect coronary accessibility, particularly in cases involving valve-in-valve (TAV-in-TAV) procedures, guiding...

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant

14 Feb 2026 – From PCR Tokyo Valves 2026

This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...

Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant

Real world outcomes and strategies for optimal TEER across diverse DMR anatomies

14 Feb 2026 – From PCR Tokyo Valves 2026

This session develops a nuanced understanding of the complexity inherent in DMR cases, informed by the latest registry data. It highlights the capabilities of the PASCAL device in managing challenging anatomies and achieving predictable clinical results, alongside contemporary strategies for device selection and optimal placement to...

Real world outcomes and strategies for optimal TEER across diverse DMR anatomies

TAVI today and tomorrow: international trends and future direction

14 Feb 2026 – From PCR Tokyo Valves 2026

This session focuses on the evolving landscape of TAVI, emphasising lifetime management strategies with a focus on the first valve implanted. It provides a comprehensive discussion on representative patient profiles, current guidelines from various countries, and future outlooks, alongside recent long-term clinical results for the balloon-expandable...

TAVI today and tomorrow: international trends and future direction

New horizons in structural heart disease therapy - Cutting-edge stroke prevention devices: WATCHMAN × SENTINEL

15 Feb 2026 – From PCR Tokyo Valves 2026

This session delves into the advances in stroke prevention for patients undergoing TAVI with atrial fibrillation, focusing on left atrial appendage closure (LAAC) and cerebral protection strategies. It highlights the evolving role of WATCHMAN devices and the SENTINEL Cerebral Protection System, emphasising perioperative stroke risk management...

New horizons in structural heart disease therapy - Cutting-edge stroke prevention devices: WATCHMAN × SENTINEL

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

14 Feb 2026 – From PCR Tokyo Valves 2026

This session highlights the critical role of cerebral protection during TAVI procedures by focusing on the SENTINEL Cerebral Protection System. It reviews trends in the United States and Japan, presents clinical outcomes one year post-introduction in Japan, and examines key clinical trials through a meta-analysis comparing...

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

REVIVED-BCIS2: no benefit of routine PCI in patients with reduced LVEF

13 Mar 2023

Dejan Milasinovic provides his take on the REVIVED trial - percutaneous revascularisation for ischaemic ventricular dysfunction, which was presented during ESC Congress 2022 in Barcelona.

Dejan Milasinovic

Author

Dejan Milasinovic
REVIVED - Percutaneous Revascularisation for Ischaemic Ventricular Dysfunction

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Sofie Brouwers

Author

Sofie Brouwers
Why hypertension is a major unresolved problem

Left Atrial Appendage Closure after Ablation for Atrial Fibrillation - the OPTION Trial

17 Nov 2024

Alessandro Sticchi provides his take on the OPTION Trial presented at AHA 2024 in Chicago.

Alessandro Sticchi

Author

Alessandro Sticchi
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation - the OPTION Trial
Didn’t find what you were looking for?